Jill Freeman, APRN
Adult Health · Woodbury, MNNPI 1639113384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 27.6% of the total. Among adult health clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $26.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$450
- Coloplast$400
- 180 Medical, Inc.$136
- Convatec Inc.$127
- AbbVie$97
- Axonics, Inc.$66
- plus $356 from 14 others
What the payments were for
- Food & beverage$1,630100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $450 |
| Coloplast | 14 | $400 |
| 180 Medical, Inc. | 6 | $136 |
| Convatec Inc. | 3 | $127 |
| AbbVie | 6 | $97 |
| Axonics, Inc. | 3 | $66 |
| Astellas Pharma US Inc | 3 | $52 |
| ABC Home Medical Supply, Inc. | 3 | $43 |
| Olympus America Inc. | 2 | $36 |
| Accord Healthcare, Inc. | 2 | $35 |
| Boston Scientific | 2 | $33 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Merck | 1 | $19 |
| Calyxo, Inc. | 1 | $18 |
| Photocure Inc | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $15 |
| Blue Earth Diagnostics | 1 | $14 |
| SRS Medical Systems, Inc. | 1 | $14 |
| Hollister Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$152
- SPEEDICATH$105
How this compares
$1,630 in reported general payments places this provider in the 90th percentile of 233 adult health providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 265 | $165,650 |
| MyrbetriqMirabegron | 138 | $105,308 |
| Methenamine Hippurate | 201 | $13,705 |
| Estradiol | 228 | $12,932 |
| Trospium Chloride ErTrospium Chloride | 59 | $11,565 |
| Tolterodine Tartrate ErTolterodine Tartrate | 149 | $10,024 |
| Mirabegron ErMirabegron | 12 | $8,029 |
| Solifenacin Succinate | 179 | $4,429 |
| Tamsulosin Hcl | 168 | $2,949 |
| Cephalexin | 320 | $2,799 |
| Trospium Chloride | 68 | $2,343 |
| Tolterodine Tartrate | 31 | $1,490 |
| Trimethoprim | 65 | $1,376 |
| Finasteride | 94 | $1,306 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 103 | $1,096 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $52 | $105,308138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 adult health providers in Minnesota.
Other adult health in Woodbury
- Rodica CatravaWoodbury$2K
- Sarah JaxSt Louis Park$86K
- Marcus BurnsMinneapolis$51K
- William SharpMinneapolis$37K
- Brian GoodroadMinneapolis$29K
- Alicia WojchikChaska$14K
- Kelli DalyEdina$11K
- Bridget FlynnMinneapolis$7K
- Devon EllenaApple Valley$7K
- Maureen VantineMinneapolis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.